0001213900-21-007907.txt : 20210210 0001213900-21-007907.hdr.sgml : 20210210 20210210061402 ACCESSION NUMBER: 0001213900-21-007907 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210210 DATE AS OF CHANGE: 20210210 EFFECTIVENESS DATE: 20210210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SenesTech, Inc. CENTRAL INDEX KEY: 0001680378 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 202079805 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-388990 FILM NUMBER: 21609159 BUSINESS ADDRESS: STREET 1: 3140 N. CADEN COURT STREET 2: SUITE 1 CITY: FLAGSTAFF STATE: AZ ZIP: 86004 BUSINESS PHONE: (928) 779 - 4143 MAIL ADDRESS: STREET 1: 3140 N. CADEN COURT STREET 2: SUITE 1 CITY: FLAGSTAFF STATE: AZ ZIP: 86004 D 1 primary_doc.xml X0708 D LIVE 0001680378 SenesTech, Inc. 23460 N 19TH AVE, SUITE 110 PHOENIX AZ ARIZONA 85027 928-779-4143 DELAWARE None None Corporation true Kenneth Siegel 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Executive Officer Director Chief Executive Officer and Director Thomas C Chesterman 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Executive Officer Chief Financial Officer Jamie Bechtel, JD, Ph.D. 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Director Delphine Chiavarini 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Director Marc Dumont 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Director Matthew Szot 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Director Jake Leach 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Director Phil Grandinetti, III 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Director K.C. Kavanagh 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Director Steven Krause, Ph.D. 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Executive Officer Executive Vice President, Sales and Marketing Kim Wolin 23460 N 19th Ave, Suite 110 Phoenix AZ ARIZONA 85027 Executive Officer Executive Vice President, Operations and Secretary Biotechnology Decline to Disclose 06b false 2021-01-27 false true true true false 0 H.C. Wainwright & Co. 375 None None 430 PARK AVE NEW YORK NY NEW YORK 10022 All States false 9999584 9999584 0 This amount does not include warrants issued to the placement agent. false 19 850000 0 In connection with the private placement, the Company paid H.C. Wainwright & Co., as placement agent, a fee of $850,000.33, which includes a cash fee of $750,000.29, a management fee of $100,000.04, as well as expense reimbursements totaling $75,000. 0 false SenesTech, Inc. /s/ Thomas C. Chesterman Thomas C. Chesterman Chief Financial Officer 2021-02-10